Lupin gets approval from USFDA for Sildenafil for oral suspension

24 Mar 2022 Evaluate

Lupin has received approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA), Sildenafil for Oral Suspension, 10 mg/mL to market a generic equivalent of Revatio for Oral Suspension, 10 mg/mL, of Viatris Specialty LLC. The product will be manufactured at Lupin's facility in Goa, India. Sildenafil for Oral Suspension, 10 mg/mL (RLD Revatio) had estimated annual sales of $66 million in the U.S. (IQVIA MAT December 2021).

Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai, India.

Lupin Share Price

2295.00 -27.45 (-1.18%)
23-Mar-2026 12:13 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1768.05
Dr. Reddys Lab 1282.00
Cipla 1243.20
Zydus Lifesciences 877.75
Lupin 2295.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×